County
Wake County EMS System
An undated version is under review. The figures below are from the current listed document.
Drugs and doses37
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Chloride, Calcium Gluconate, Cefazolin9
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12 mg | IV/IO | not captured | standing | pages 32, 75 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 32, 75 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 77 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | pages 7, 13 |
| Asthma / bronchospasm | peds | 5 mg | NEB | not captured | standing | pages 7, 13 |
| Respiratory distress | adult | 5 mg | NEB | not captured | standing | pages 7, 13 |
| Respiratory distress | peds | 5 mg | NEB | not captured | standing | pages 7, 13 |
| Stridor | adult | 5 mg | NEB | not captured | standing | pages 7, 13 |
| Stridor | peds | 5 mg | NEB | not captured | standing | pages 7, 13 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 39, 79 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 39, 79 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 32, 33, 35, 77 |
| Narrow-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 32, 33, 35, 77 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 28 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 24, 70 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 24, 70 |
| Nerve agent exposure | adult | 2 mg | IV/IO/IM | not captured | standing | pages 108, 109 |
| Other | adult | 1 mg | IV | not captured | standing | page 22 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | pages 110, 111 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | pages 22, 131 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 61 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | pages 22, 131 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3 g | IV/IO | not captured | standing | page 106 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3 g | IV/IO | not captured | standing | page 106 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 61, 106 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 133 |
D–F Dexamethasone, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Famotidine, Fentanyl, Furosemide9
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 10 mg | IV/IO/IM/PO | not captured | standing | pages 7, 13, 57, 83 |
| Respiratory distress | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | pages 7, 13, 57, 83 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 20 mg | IV/IO | not captured | standing | pages 32, 33 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | PO | not captured | standing | pages 57, 83 |
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 57, 83 |
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 57, 83 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | pages 57, 83 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 57, 83 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 57, 83 |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | pages 57, 83 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 57, 83 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 24, 71 |
| Bradycardia | peds | 5–20 mcg/kg | IV/IO | not captured | standing | pages 24, 71 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV/IO | not captured | standing | pages 69, 71, 74, 87 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 7, 57, 83 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 7, 57, 83 |
| Bradycardia | adult | 2–30 mcg | IV/IO | not captured | standing | pages 24, 70, 71 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 22, 39, 68, 79 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 22, 39, 68, 79 |
| Hypotension / shock | peds | 0.05–5 mcg/kg | IV/IO | not captured | standing | pages 64, 87 |
| Stridor | adult | 1 mg | NEB | not captured | standing | pages 7, 13 |
| Stridor | peds | 1 mg | NEB | not captured | standing | pages 7, 13 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 46 |
| Other | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 46 |
| Procedural sedation | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 15 |
| Procedural sedation | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 15 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20–40 mg | IV/IO/PO | not captured | standing | pages 57, 83 |
| Allergic reaction | peds | 0.25 mg/kg | IV/IO/PO | not captured | standing | pages 57, 83 |
| Anaphylaxis | adult | 20–40 mg | IV/IO/PO | not captured | standing | pages 57, 83 |
| Anaphylaxis | peds | 0.25 mg/kg | IV/IO/PO | not captured | standing | pages 57, 83 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50 mcg | IV/IO/IM/IN | not captured | standing | page 28 |
| CHF / pulmonary edema | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 72 |
| Other | adult | 50–75 mcg | IV/IO | not captured | standing | page 15 |
| Other | peds | 1 mcg/kg | IV/IO | not captured | standing | page 15 |
| Procedural sedation | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 24 |
| Procedural sedation | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 32, 33, 35, 37, 75, 77 |
| Procedural sedation | peds | 2 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 32, 33, 35, 37, 75, 77 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 40 mg | IV/IO | not captured | standing | page 52 |
G–L Glucagon, Haloperidol, Hydrocortisone, Hydroxocobalamin, Ipratropium, Lidocaine, Lorazepam7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO/IM | not captured | standing | pages 22, 106 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 22, 106 |
| Hypoglycemia | adult | 1–2 mg | IM | not captured | standing | pages 59, 85 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 59, 85 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg | IV/IM/SQ | not captured | standing | page 125 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | pages 65, 88 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 65, 88 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 97 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 97 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | pages 7, 13 |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | pages 7, 13 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IO | not captured | standing | page 79 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 79 |
| Wide-complex tachycardia | adult | 100 mg | IV/IO | not captured | standing | pages 35, 37 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV/IM/SQ | not captured | standing | page 125 |
M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oxytocin8
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 g | IV/IO | not captured | standing | pages 39, 79 |
| Cardiac arrest | peds | 40 mg/kg | IV/IO | not captured | standing | pages 39, 79 |
| Respiratory distress | adult | 2 g | IV/IO | not captured | standing | pages 7, 13 |
| Respiratory distress | peds | 40 mg/kg | IV/IO | not captured | standing | pages 7, 13 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 37, 79 |
| VF / pulseless VT | peds | 40 mg/kg | IV/IO | not captured | standing | pages 37, 79 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg | IV | not captured | standing | pages 8, 31 |
| Other | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 95 |
| Other | adult | 2.5 mg | IV/IO | not captured | standing | page 15 |
| Other | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 15 |
| Other | peds | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | page 95 |
| Procedural sedation | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | pages 24, 70 |
| Procedural sedation | adult | 2.5 mg | IV/IO/IM/IN | not captured | standing | pages 32, 33, 35, 37, 75, 77 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 32, 33, 35, 37, 75, 77 |
| Procedural sedation | peds | 0.1–0.2 mg/kg | IV/IO/IM/IN | not captured | standing | pages 24, 70 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 93 |
| Seizure | peds | 2.5 mg | IM | not captured | standing | page 93 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 72 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 mg | IV/IO | not captured | standing | page 22 |
| Opioid overdose | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 23, 27, 68, 73, 105 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 23, 27, 68, 73, 105 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 28 |
| ACS / chest pain | adult | 1–2 inch | TOP | not captured | standing | page 28 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 30 |
| CHF / pulmonary edema | adult | 1–2 inch | TOP | not captured | standing | page 30 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–30 mcg | IV | not captured | standing | page 30 |
| Hypotension / shock | adult | 2–30 mcg | IV/IO | not captured | standing | pages 64, 87 |
| Hypotension / shock | adult | 2–30 mcg | IV/IO | not captured | standing | page 41 |
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | pages 64, 87 |
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | page 41 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/ODT | not captured | standing | page 144 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IO/IM/PO/ODT | not captured | standing | page 144 |
| Other | adult | 4 mg | SL | not captured | standing | pages 110, 111 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | pages 89, 90, 93 |
P–R Pralidoxime, Promethazine2
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IV/IO/IM | not captured | standing | page 108 |
| Nerve agent exposure | peds | 15–25 mg/kg | IV/IO/IM | not captured | standing | page 108 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 25 mg | IV/IM | not captured | standing | page 125 |
S–Z Sodium Bicarbonate, Tranexamic Acid2
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 22, 61, 131 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 22, 61, 131 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 106 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 106 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 136 |
Cite this
Wake County EMS System, United States EMS Protocol Census. 121 dose entries, effective 2026-04-01.
https://protoquiz.com/census/agencies/wake-county-ems-system/
The census is free and not for sale. Only public agencies are named.